Global Macular Degeneration Testing and Therapeutics Market - Forecasts from 2018 to 2023

Global Macular Degeneration Testing and Therapeutics Market - Forecasts from 2018 to 2023

The global macular degeneration testing and therapeutics market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. The demand for age-related macular degeneration testing and therapeutics is growing due to the rising aging population and growing number of surgical procedures. Macular Degeneration is the leading cause of vision loss, affecting more than 10 million Americans (American Macular Degeneration Foundation). North America is expected to show a significant market share followed by the Asia Pacific which is expected to show a high market growth owing to the growing awareness regarding self-care and self-management in the forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global macular degeneration testing and therapeutics value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global macular degeneration testing and therapeutics market.

Major industry players profiled as part of the report are Good-Lite Co., Leica Microsystems GmbH, Optovue, Incorporated, Heidelberg Engineering GmbH and TOPCON CORPORATION among others.

Segmentation

The global macular degeneration testing and therapeutics market has been analyzed through following segments:

By Macular Degeneration Type

Dry (Atrophic)

Wet (Exudative)


By Testing and Treatment

Amsler Grid

Optical Coherence Tomography (OCT)

Laser Surgery

Others


By Geography

North America

USA

Canada

Mexico

Others


South America

Brazil

Argentina

Others


Europe

Germany

France

United Kingdom

Spain

Others


Middle East and Africa

Saudi Arabia

Israel

Others


Asia Pacific

China

Japan

South Korea

India

Others


Target audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants


Key insights offered

What will be the global macular degeneration testing and therapeutics market size from 2017 to 2023?

How are the major drivers and restraints affecting the global macular degeneration testing and therapeutics market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL MACULAR DEGENERATION TESTING AND THERAPEUTICS MARKET BY MACULAR DEGENERATION TYPE
5.1. Dry (Atrophic)
5.2. Wet (Exudative)
6. GLOBAL MACULAR DEGENERATION TESTING AND THERAPEUTICS MARKET BY TESTING AND TREATMENT
6.1. Amsler Grid
6.2. Optical Coherence Tomography (OCT)
6.3. Laser Surgery
6.4. Others
7. GLOBAL MACULAR DEGENERATION TESTING AND THERAPEUTICS MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentia
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1.  Market Share of Key Players
8.2.  Recent Investment and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Good-Lite Co.
9.1.1. Company Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Recent Developments
9.2. Leica Microsystems GmbH
9.2.1. Company Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Recent Developments
9.3.  Optovue, Incorporated
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Recent Developments
9.4. Heidelberg Engineering GmbH
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Recent Developments
9.5.  TOPCON CORPORATION
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Recent Developments
9.6. Nano Retina
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Products and Services
9.6.4. Recent Developments
9.7. MacuHealth
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Products and Services
9.7.4. Recent Developments
9.8. LumiThera, Inc.
9.8.1. Company Overview
9.8.2. Financials
9.8.3. Products and Services
9.8.4. Recent Developments
9.9. Ellex Medical
9.9.1. Company Overview
9.9.2. Financials
9.9.3. Products and Services
9.9.4. Recent Developments
9.10. Quantel Medical
9.10.1. Company Overview
9.10.2. Financials
9.10.3. Products and Services
9.10.4. Recent Developments
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER 

Good-Lite Co.

Leica Microsystems GmbH

Optovue, Incorporated

Heidelberg Engineering GmbH

TOPCON CORPORATION

Nano Retina

MacuHealth

LumiThera, Inc.

Ellex Medical

Quantel Medical

  • SKU:
  • Publishing Date: 2018-11-23
  • Product Code: 1
  • Availability: In Stock
  • $3,800.00
  • Ex Tax: $3,800.00

Available Options